| 1.0 |
3.1 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.9 |
3.8 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.9 |
2.8 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.9 |
4.4 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.8 |
2.5 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
| 0.8 |
2.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.8 |
2.4 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.7 |
0.7 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.7 |
1.4 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.6 |
3.0 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.6 |
1.8 |
GO:0014874 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.6 |
1.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.6 |
1.8 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.6 |
2.2 |
GO:0010903 |
negative regulation of cytokine secretion involved in immune response(GO:0002740) negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.6 |
3.3 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.6 |
2.2 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.5 |
2.1 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.5 |
1.6 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.5 |
2.6 |
GO:0010993 |
ubiquitin homeostasis(GO:0010992) regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.5 |
1.1 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.5 |
3.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.5 |
1.6 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.5 |
1.6 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.5 |
2.6 |
GO:0070884 |
calcineurin-NFAT signaling cascade(GO:0033173) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.5 |
2.0 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.5 |
1.5 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.5 |
4.4 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.5 |
1.4 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.5 |
3.7 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.5 |
1.8 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.5 |
1.4 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.4 |
2.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.4 |
1.3 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.4 |
0.4 |
GO:0071639 |
heterotypic cell-cell adhesion(GO:0034113) regulation of heterotypic cell-cell adhesion(GO:0034114) positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.4 |
0.9 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.4 |
3.0 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.4 |
1.7 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.4 |
1.3 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.4 |
0.4 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.4 |
1.7 |
GO:0031223 |
auditory behavior(GO:0031223) |
| 0.4 |
4.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.4 |
1.2 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.4 |
1.2 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.4 |
3.2 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.4 |
1.2 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.4 |
2.3 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.4 |
1.5 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.4 |
1.5 |
GO:0010716 |
regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
| 0.4 |
1.8 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.4 |
2.5 |
GO:2000109 |
positive regulation of myeloid cell apoptotic process(GO:0033034) macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.4 |
0.4 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.3 |
1.0 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 |
1.0 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.3 |
1.0 |
GO:0018243 |
protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 |
1.0 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.3 |
0.7 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.3 |
1.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.3 |
0.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.3 |
0.7 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 |
1.0 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
| 0.3 |
1.0 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.3 |
1.0 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
| 0.3 |
1.3 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.3 |
0.9 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
3.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
1.8 |
GO:0002921 |
negative regulation of humoral immune response(GO:0002921) negative regulation of protein processing(GO:0010955) negative regulation of complement activation(GO:0045916) negative regulation of protein maturation(GO:1903318) negative regulation of protein activation cascade(GO:2000258) |
| 0.3 |
0.6 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.3 |
1.2 |
GO:0051875 |
melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
| 0.3 |
1.2 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.3 |
2.4 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 |
0.6 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.3 |
2.6 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.3 |
2.0 |
GO:0060347 |
heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
| 0.3 |
1.4 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 |
1.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.3 |
0.6 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.3 |
0.5 |
GO:0060433 |
bronchus development(GO:0060433) |
| 0.3 |
1.6 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.3 |
2.1 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.3 |
1.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
1.1 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.3 |
1.8 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.3 |
1.3 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
| 0.3 |
7.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
2.5 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.3 |
0.8 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
0.5 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.2 |
0.7 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
1.5 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.2 |
0.5 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.2 |
0.7 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.2 |
0.9 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 |
0.7 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.2 |
0.9 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.2 |
0.2 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.2 |
2.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
1.1 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.2 |
4.6 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.2 |
3.7 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
0.9 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.2 |
3.0 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.2 |
0.4 |
GO:0071883 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 |
0.6 |
GO:0007028 |
cytoplasm organization(GO:0007028) ribonucleoprotein complex disassembly(GO:0032988) |
| 0.2 |
2.1 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 |
0.9 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.2 |
0.4 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 |
1.7 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.2 |
1.4 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
0.8 |
GO:0042749 |
circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.2 |
1.0 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
2.4 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.2 |
1.6 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 |
1.0 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 |
2.5 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.2 |
2.7 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.2 |
1.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.2 |
0.6 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 |
1.1 |
GO:0014031 |
mesenchymal cell development(GO:0014031) stem cell development(GO:0048864) |
| 0.2 |
0.2 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.2 |
0.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 |
0.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
2.4 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.2 |
1.1 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
1.1 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 |
0.9 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 |
0.2 |
GO:0051891 |
positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
| 0.2 |
0.2 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.2 |
1.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
0.4 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 |
0.7 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.2 |
0.5 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 |
1.0 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
1.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.8 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.2 |
3.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
0.8 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
3.9 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.2 |
0.2 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.2 |
0.8 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) |
| 0.2 |
2.3 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
0.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.2 |
0.6 |
GO:1902414 |
protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.2 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
1.6 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.2 |
0.9 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.2 |
0.5 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.2 |
0.6 |
GO:0010915 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.2 |
0.9 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
12.6 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.1 |
1.0 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.3 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.4 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.3 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.1 |
0.4 |
GO:0014831 |
intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.1 |
0.7 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.1 |
0.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
1.0 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
0.6 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
1.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
2.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 |
0.1 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.8 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 |
0.5 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.7 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 |
0.1 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.1 |
0.9 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
2.5 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.1 |
1.2 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
1.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.6 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.1 |
0.4 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 |
0.1 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 |
0.4 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
0.6 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.1 |
0.4 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
1.2 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 |
0.2 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.1 |
2.7 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.7 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.5 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.6 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.5 |
GO:0034599 |
cellular response to oxidative stress(GO:0034599) |
| 0.1 |
0.7 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
0.8 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
1.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
11.1 |
GO:0030832 |
regulation of actin filament length(GO:0030832) |
| 0.1 |
0.4 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 |
1.2 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.4 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
1.5 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.1 |
0.3 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.1 |
0.3 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.1 |
0.3 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 |
0.3 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.3 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.7 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.2 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.8 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.1 |
GO:0032672 |
regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.1 |
1.5 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 |
0.9 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
1.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.5 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.1 |
0.2 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
| 0.1 |
0.3 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 |
0.3 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.1 |
0.4 |
GO:0048743 |
RNA folding(GO:0034337) DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) regulation of DNA methylation(GO:0044030) positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 |
1.1 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 |
0.5 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
2.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.3 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
0.4 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.3 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.1 |
1.2 |
GO:0003407 |
neural retina development(GO:0003407) |
| 0.1 |
0.8 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.2 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 |
0.6 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.3 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) |
| 0.1 |
1.1 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.7 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.5 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.1 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.5 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.1 |
1.0 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
1.6 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 |
0.3 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.1 |
0.4 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
0.3 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.1 |
0.1 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
| 0.1 |
0.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.3 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.3 |
GO:0035269 |
protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
| 0.1 |
0.3 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 |
0.3 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) positive regulation of pinocytosis(GO:0048549) positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
1.0 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
0.2 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.6 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.1 |
0.2 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.2 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.1 |
0.4 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.7 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
1.7 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
0.2 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.1 |
0.2 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.9 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.1 |
0.7 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.8 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.2 |
GO:0006531 |
aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.1 |
0.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.5 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
1.5 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.1 |
1.2 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.5 |
GO:0034465 |
cellular potassium ion homeostasis(GO:0030007) response to carbon monoxide(GO:0034465) negative regulation of cell volume(GO:0045794) smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 |
0.2 |
GO:0043501 |
skeletal muscle adaptation(GO:0043501) |
| 0.1 |
0.4 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.5 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.2 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
| 0.1 |
0.1 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.1 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
1.3 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.2 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.1 |
0.3 |
GO:0002331 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) lipoprotein catabolic process(GO:0042159) |
| 0.1 |
0.2 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
5.2 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.1 |
0.9 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
1.4 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.1 |
0.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.2 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.2 |
GO:0009612 |
response to mechanical stimulus(GO:0009612) |
| 0.1 |
0.1 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.1 |
0.2 |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.1 |
2.0 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.7 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.1 |
0.4 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.1 |
3.1 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.1 |
0.3 |
GO:0001960 |
negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
| 0.1 |
0.5 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.1 |
GO:0030851 |
myeloid leukocyte differentiation(GO:0002573) granulocyte differentiation(GO:0030851) |
| 0.1 |
0.2 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.6 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.1 |
0.8 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.1 |
1.3 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.1 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.5 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.6 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
0.2 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.1 |
0.2 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
0.3 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.1 |
0.2 |
GO:0050932 |
regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
| 0.1 |
0.1 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.1 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.5 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
1.3 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.1 |
0.4 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 |
0.2 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
0.1 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.1 |
GO:0014721 |
voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 |
0.2 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.1 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.1 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
0.3 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.1 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 |
0.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.5 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.6 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
0.4 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 |
1.2 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.1 |
0.7 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
0.1 |
GO:0072677 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.1 |
2.3 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
| 0.1 |
0.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.6 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
3.3 |
GO:0006914 |
autophagy(GO:0006914) |
| 0.1 |
0.4 |
GO:0030041 |
actin filament polymerization(GO:0030041) |
| 0.1 |
0.8 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
1.8 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.1 |
0.3 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.1 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.5 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.1 |
0.2 |
GO:1903020 |
positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 |
0.1 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
0.2 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.6 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.1 |
0.3 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.6 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.3 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.1 |
0.5 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.4 |
GO:0042987 |
amyloid precursor protein catabolic process(GO:0042987) |
| 0.1 |
0.8 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 |
0.6 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.3 |
GO:1903513 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) endoplasmic reticulum to cytosol transport(GO:1903513) |
| 0.0 |
0.0 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.0 |
0.2 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.4 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.2 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
| 0.0 |
0.1 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.0 |
0.0 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.0 |
0.8 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
3.0 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
0.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.8 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.0 |
0.2 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.2 |
GO:0030278 |
regulation of ossification(GO:0030278) |
| 0.0 |
0.0 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.2 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
2.3 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.0 |
0.1 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.0 |
2.4 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
| 0.0 |
3.6 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
0.3 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
2.1 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.3 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.0 |
1.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
1.0 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.0 |
GO:0002385 |
innate immune response in mucosa(GO:0002227) organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.1 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.5 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 |
0.1 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.0 |
0.3 |
GO:0015800 |
acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.0 |
0.2 |
GO:0051209 |
sequestering of calcium ion(GO:0051208) release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
| 0.0 |
0.1 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.4 |
GO:0032094 |
response to food(GO:0032094) |
| 0.0 |
0.0 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.0 |
0.3 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.0 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.0 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.0 |
0.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.1 |
GO:0002124 |
territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) male courtship behavior(GO:0008049) vocalization behavior(GO:0071625) |
| 0.0 |
0.2 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.0 |
0.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.1 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.0 |
0.3 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.0 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.3 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0034650 |
cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
| 0.0 |
0.1 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.0 |
0.7 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.0 |
0.1 |
GO:0046639 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.0 |
0.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.0 |
0.1 |
GO:0070254 |
mucus secretion(GO:0070254) |
| 0.0 |
0.3 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 |
0.3 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.0 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.0 |
0.2 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
4.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:0006200 |
obsolete ATP catabolic process(GO:0006200) |
| 0.0 |
0.2 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.0 |
0.2 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
| 0.0 |
0.3 |
GO:1901264 |
carbohydrate derivative transport(GO:1901264) |
| 0.0 |
0.1 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.0 |
0.2 |
GO:0071674 |
mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
| 0.0 |
0.7 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.7 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.1 |
GO:1901661 |
quinone metabolic process(GO:1901661) |
| 0.0 |
0.5 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.9 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
| 0.0 |
0.3 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 |
0.3 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.7 |
GO:0030336 |
negative regulation of cell migration(GO:0030336) negative regulation of cell motility(GO:2000146) |
| 0.0 |
1.0 |
GO:0030282 |
bone mineralization(GO:0030282) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.7 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 |
0.2 |
GO:0032647 |
interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
| 0.0 |
0.1 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.0 |
0.7 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 |
0.1 |
GO:0043954 |
cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
| 0.0 |
0.4 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.1 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.1 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.5 |
GO:0043588 |
skin development(GO:0043588) |
| 0.0 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
1.1 |
GO:0097479 |
synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
| 0.0 |
0.6 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.2 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.4 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.0 |
0.7 |
GO:0030866 |
cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.1 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.0 |
0.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.2 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.0 |
0.7 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.0 |
1.0 |
GO:0030323 |
respiratory tube development(GO:0030323) |
| 0.0 |
0.7 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.1 |
GO:0042130 |
negative regulation of T cell proliferation(GO:0042130) |
| 0.0 |
0.0 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.0 |
0.7 |
GO:0006029 |
proteoglycan metabolic process(GO:0006029) |
| 0.0 |
0.1 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.0 |
0.1 |
GO:0035120 |
post-embryonic appendage morphogenesis(GO:0035120) |
| 0.0 |
0.1 |
GO:0032849 |
regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
| 0.0 |
1.1 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.2 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.0 |
0.1 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 |
0.2 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.2 |
GO:0061035 |
regulation of cartilage development(GO:0061035) |
| 0.0 |
0.1 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.1 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
| 0.0 |
0.1 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.3 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.9 |
GO:0001764 |
neuron migration(GO:0001764) |
| 0.0 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.1 |
GO:0045652 |
megakaryocyte differentiation(GO:0030219) regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 0.0 |
1.8 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.3 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
1.7 |
GO:0031589 |
cell-substrate adhesion(GO:0031589) |
| 0.0 |
0.1 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.0 |
0.1 |
GO:0016045 |
detection of bacterium(GO:0016045) |
| 0.0 |
0.0 |
GO:0060129 |
corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.0 |
0.0 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.0 |
0.0 |
GO:0017014 |
protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
| 0.0 |
0.1 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 |
1.2 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.0 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.1 |
GO:0048341 |
renal glucose absorption(GO:0035623) paraxial mesoderm formation(GO:0048341) |
| 0.0 |
0.0 |
GO:0070509 |
calcium ion import(GO:0070509) |
| 0.0 |
0.9 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.3 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.0 |
0.2 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.0 |
0.2 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.7 |
GO:1901879 |
regulation of protein depolymerization(GO:1901879) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.1 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.2 |
GO:0051924 |
regulation of calcium ion transport(GO:0051924) |
| 0.0 |
0.1 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 |
0.0 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.0 |
0.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.4 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:0060014 |
granulosa cell differentiation(GO:0060014) |
| 0.0 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.2 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.5 |
GO:0006081 |
cellular aldehyde metabolic process(GO:0006081) |
| 0.0 |
2.0 |
GO:0006936 |
muscle contraction(GO:0006936) |
| 0.0 |
0.1 |
GO:0042593 |
carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.0 |
0.3 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.2 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.0 |
GO:0072332 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.0 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.7 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.1 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) |
| 0.0 |
0.0 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.0 |
0.1 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.1 |
GO:0071599 |
otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
| 0.0 |
0.6 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.2 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.0 |
0.8 |
GO:0008544 |
epidermis development(GO:0008544) |
| 0.0 |
0.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.0 |
GO:0032717 |
negative regulation of interleukin-8 production(GO:0032717) |
| 0.0 |
0.8 |
GO:0034249 |
negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
| 0.0 |
0.0 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.0 |
0.1 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.0 |
0.0 |
GO:0042364 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) water-soluble vitamin biosynthetic process(GO:0042364) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.0 |
2.0 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.0 |
0.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.3 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
0.0 |
GO:0032236 |
obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
| 0.0 |
0.2 |
GO:0006941 |
striated muscle contraction(GO:0006941) |
| 0.0 |
0.1 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.1 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.1 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.0 |
0.0 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) positive regulation of binding(GO:0051099) |
| 0.0 |
0.0 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.0 |
GO:0023014 |
MAPK cascade(GO:0000165) signal transduction by protein phosphorylation(GO:0023014) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
1.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.6 |
GO:0016197 |
endosomal transport(GO:0016197) |
| 0.0 |
0.3 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.0 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
0.0 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.3 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
1.6 |
GO:0071466 |
xenobiotic metabolic process(GO:0006805) response to xenobiotic stimulus(GO:0009410) cellular response to xenobiotic stimulus(GO:0071466) |
| 0.0 |
0.0 |
GO:0001991 |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
| 0.0 |
0.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.3 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.2 |
GO:0007613 |
memory(GO:0007613) |
| 0.0 |
0.4 |
GO:0043542 |
endothelial cell migration(GO:0043542) |
| 0.0 |
0.1 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 |
0.7 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.1 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 |
0.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.0 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.0 |
0.0 |
GO:0051445 |
regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
| 0.0 |
0.1 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) |
| 0.0 |
0.0 |
GO:0034635 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.0 |
0.1 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.0 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
0.1 |
GO:0048863 |
stem cell differentiation(GO:0048863) |
| 0.0 |
0.0 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.0 |
0.2 |
GO:0006184 |
obsolete GTP catabolic process(GO:0006184) |
| 0.0 |
0.0 |
GO:0072028 |
ureteric bud morphogenesis(GO:0060675) renal tubule morphogenesis(GO:0061333) nephron morphogenesis(GO:0072028) nephron tubule morphogenesis(GO:0072078) nephron epithelium morphogenesis(GO:0072088) mesonephric tubule morphogenesis(GO:0072171) |
| 0.0 |
0.1 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.5 |
GO:0007586 |
digestion(GO:0007586) |
| 0.0 |
0.1 |
GO:0098754 |
detoxification(GO:0098754) |
| 0.0 |
0.0 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.3 |
GO:0006887 |
exocytosis(GO:0006887) |
